Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myfortic GI Tolerability in Heart Transplant
NCT00574197Phase 4Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Jun 2006
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate sodium in heart transplant rejection, sponsored by Cedars-Sinai Medical Center. Started Jun 2006; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
heart transplant rejection
Beyond the preview
Go deeper on NCT00574197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574197.